CMS reimbursement proposals to have 'biblical impact'

The latest stories trending on MedCity News.

Editor's Pick

Top Story 'This Is Almost Biblical in Its Impact': Providers Push Back Against CMS' New Proposed Rules CMS recently revealed its proposals to raise reimbursement rates for hospital outpatient departments and cut payments for physicians. Next year, the agency is planning to decrease physicians' pay by 1.25% and increase outpatient payment rates by 2.8%. Provider groups are unhappy with the news — AMA President Dr. Jesse Ehrenfeld said the new physician fee schedule will be "almost biblical in its impact." Sponsored Content Take Our Survey! How Do Consultants View The Healthcare Landscape and Employee Benefits? Presented by MedCity News Your experience positions you to be a thought leader so your participation is vital to this research. We will use the data gathered from this survey for a report exploring how the role of the consultant is evolving, in line with the needs of self-insured employers and the shifting healthcare landscape. We value your input.  Click here to take the survey.  If you complete the survey, you will be eligible for a $250 gift card.

Featured News

It's Time to Make Effective Alternatives a Bigger Part of the CPAP Recall Story For those unfamiliar with the CPAP recall situation in question, imagine if one-third of all cars on the road were suddenly recalled for potentially life-threatening issues. Now imagine that in the aforementioned hypothetical automobile recall, the media dedicated its energy almost entirely to reporting on the worsening problem without making viewers aware of potential solutions. Health Net Invests $46M To Support Unhoused in California Health Net is making a $46 million investment that will be spread out across 26 counties in California, and will support Continuum of Care programs, which are regional or local planning bodies that help those experiencing homelessness find housing and other services. Two Biotechs Break the IPO Dry Spell, Raising $385M Combined Inflammation and immunology biotech Apogee Therapeutics and Sagimet Biosciences, a company developing a drug for the fatty liver disease NASH, are the latest biotech companies to join the public markets. Both companies upsized their IPOs, raising cash for clinical trials.

Resources

Sponsored Content MedCity Pivot Podcast: 2 Perspectives on how AI Can Soothe Burnout, Burden of Prior Authorization We interviewed Punit Singh Soni, CEO of Suki, who has developed an AI voice assistant to automate clinical documentation. We also interviewed Niall O' Connor, chief technology officer, Cohere Health who uses AI to streamline the burdensome process of prior authorization. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe